bromide and vilanterol

bromide has been researched along with vilanterol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Cazzola, M; Matera, MG; Rinaldi, B; Rogliani, P1
Birk, R; Farrell, C; Hayes, S; Lipson, DA; Mehta, R; Okour, M1
Fowler, A; Lee, LA; Peachey, G; Sule, N; Yang, S1
Bolotova, EV; Dudnikova, AV; Shulzhenko, LV1

Reviews

1 review(s) available for bromide and vilanterol

ArticleYear
Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease.
    Expert review of clinical pharmacology, 2015, Volume: 8, Issue:1

    Topics: Benzyl Alcohols; Bromides; Bronchodilator Agents; Chlorobenzenes; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Humans; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Randomized Controlled Trials as Topic

2015

Trials

2 trial(s) available for bromide and vilanterol

ArticleYear
Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.
    Clinical pharmacokinetics, 2020, Volume: 59, Issue:1

    Topics: Administration, Inhalation; Aged; Androstadienes; Anticonvulsants; Benzyl Alcohols; Bromides; Chlorobenzenes; Drug Combinations; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Quinuclidines

2020
Population Pharmacokinetic Modeling of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol in Patients with Asthma, Using Data from a Phase IIIA Study (CAPTAIN).
    Clinical pharmacokinetics, 2021, Volume: 60, Issue:7

    Topics: Administration, Inhalation; Androstadienes; Asthma; Benzyl Alcohols; Bromides; Chlorobenzenes; Double-Blind Method; Drug Combinations; Humans; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Treatment Outcome

2021

Other Studies

1 other study(ies) available for bromide and vilanterol

ArticleYear
[Experience of using a triple fixed combination in the treatment of patients with chronic obstructive pulmonary disease].
    Terapevticheskii arkhiv, 2022, Mar-15, Volume: 94, Issue:3

    Topics: Administration, Inhalation; Benzyl Alcohols; Bromides; Bronchodilator Agents; Chlorobenzenes; Drug Combinations; Humans; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinuclidines; Treatment Outcome

2022